My ongoing project focuses on the role of RNA modifications in breast cancer spliceosomal vulnerability. I am trying to deeply investigate the protective role that RNA modifications like m6A play towards the innate immune response pathway. My goal is to unravel potential combined therapies with RNA modification inhibitors and splicing inhibitors to efficiently target Myc driven cancers.